MiR-486 regulates cardiomyocyte apoptosis by p53-mediated BCL-2 associated mitochondrial apoptotic pathway

BMC Cardiovascular Disorders

Volumn 17, Issue 1, 2017, Pages

  Sun, Yuhan ^a   Su, Qiang ^a   Li, Lang ^a   Wang, Xiantao ^a   Lu, Yuanxi ^a   Liang, Jiabao ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; BCL 2 pathway; Cardiomyocyte; MiR 486; P53

Indexed keywords

CASPASE 3; CLEAVED CASPASE 3; MICRORNA; MICRORNA 486; PROTEIN BCL 2; PROTEIN P53; PUMA PROTEIN; UNCLASSIFIED DRUG; BCL2 PROTEIN, RAT; HYDROGEN PEROXIDE; MESSENGER RNA; MIRN486 MICRORNA, RAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CONTROLLED STUDY; FLOW CYTOMETRY; MITOCHONDRIAL DYNAMICS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TUNEL ASSAY; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEART MITOCHONDRION; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; SUCKLING ANIMAL;

ANIMALS; ANIMALS, SUCKLING; APOPTOSIS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HYDROGEN PEROXIDE; MICRORNAS; MITOCHONDRIA, HEART; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85019158505     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-017-0549-7     Document Type: Article

References (30)

1. Peng Y, Dai Y, Hitchcock C, Yang X, Kassis ES, Liu L, et al. Insulin growth factor signaling is regulated by microRNA-486, an under expressed microRNA in lung cancer. Proc Natl Acad Sci U S A. 2013;110(37):15043-8.
2. Hall AE, Lu WT, Godfrey JD, Antonov AV, Paicu C, Moxon S, et al. The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration. Cell Death Dis. 2016;7:e2184.
3. Zhang G, Liu Z, Cui G, Wang X, Yang Z. MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells. Tumour Biol. 2014;35(11):11137-45.
4. Shi XF, Wang H, Xiao FJ, Yin Y, Xu QQ, Ge RL, et al. MiRNA-486 regulates angiogenic activity and survival of mesenchymal stem cells under hypoxia through modulating Akt signal. Biochem Biophys Res Commun. 2016;470(3):670-7.
5. Budhram-Mahadeo V, Fujita R, Bitsi S, Sicard P, Heads R. Co-expression of POU4F2/Brn-3b with p53 may be important for controlling expression of pro-apoptotic genes in cardiomyocytes following ischemic/hypoxic insults. Cell Death Dis. 2014;5:e1503.
6. Su Q, Li L, Zhou Y, Wang J, Liu Y, Ma G. Induction of myocardial PDCD4 in coronary microembolization-related cardiac dysfunction: evidence from a large-animal study. Cell Physiol Biochem. 2014;34(2):533-42.
7. Su Q, Li L, Liu Y, Zhou Y, Wang J, Wen W. Ultrasound-targeted microbubble destruction-mediated microRNA-21 transfection regulated PDCD4/NF-kappaB/TNF-alpha pathway to prevent coronary microembolization-induced cardiac dysfunction. Gene Ther. 2015;22(12):1000-6.
8. Vavrova J, Rezacova M. Importance of proapoptotic protein PUMA in cell radioresistance. Folia Biol (Praha). 2014;60(2):53-6.
9. Hikisz P, Kilianska ZM. PUMA, a critical mediator of cell death--one decade on from its discovery. Cell Mol Biol Lett. 2012;17(4):646-69.
10. Fujita T, Ishikawa Y. Apoptosis in heart failure. -the role of the beta-adrenergic receptor-mediated signaling pathway and p53-mediated signaling pathway in the apoptosis of cardiomyocytes. Circ J. 2011;75(8):1811-8.
11. Hua Y, Nair S. Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications. Biochim Biophys Acta. 2015;1852(2):195-208.
12. Dlamini Z, Tshidino SC, Hull R. Abnormalities in alternative splicing of apoptotic genes and cardiovascular diseases. Int J Mol Sci. 2015;16(11):27171-90.
13. Jose Corbalan J, Vatner DE, Vatner SF. Myocardial apoptosis in heart disease: does the emperor have clothes Basic Res Cardiol. 2016;111(3):31.
14. Baban B, Liu JY, Mozaffari MS. Pressure overload regulates expression of cytokines, gammaH2AX, and growth arrest- and DNA-damage inducible protein 153 via glycogen synthase kinase-3beta in ischemic-reperfused hearts. Hypertension. 2013;61(1):95-104.
15. Cui H, Li N, Li X, Qi K, Li Q, Jin C, et al. Tongxinluo modulates cytokine secretion by cardiac microvascular endothelial cells in ischemia/reperfusion injury. Am J Transl Res. 2016;8(10):4370-81.
16. Khanabdali R, Rosdah AA, Dusting GJ, Lim SY. Harnessing the secretome of cardiac stem cells as therapy for ischemic heart disease. BiochemPharmacol. 2016;113:1-11.
17. Quattrocelli M, Crippa S, Montecchiani C, Camps J, Cornaglia AI, Boldrin L, et al. Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice. J Am Heart Assoc. 2013;2(4):e000284.
18. Ramanujam D, Sassi Y, Laggerbauer B, Engelhardt S. Viral vector-based targeting of miR-21 in cardiac Nonmyocyte cells reduces pathologic remodeling of the heart. Mol Ther. 2016;24(11):1939-1948.
19. Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J, et al. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation. 2010;122(13):1308-18.
20. Ohtani K, Dimmeler S. Control of cardiovascular differentiation by microRNAs. Basic Res Cardiol. 2011;106(1):5-11.
21. Raut SK, Singh GB, Rastogi B, Saikia UN, Mittal A, Dogra N, et al. miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy. Mol Cell Biochem. 2016;417(1-2):191-203.
22. 2-induced apoptosis. Acta Pharmacol Sin. 2016;37(11):1413-22.
23. Zeestraten EC, Benard A, Reimers MS, Schouten PC, Liefers GJ, van de Velde CJ, et al. The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry. Biomark Cancer. 2013;5:13-29.
24. Su Q, Li L, Liu YC, Zhou Y, Lu YG, Wen WM. Effect of metoprolol on myocardial apoptosis and caspase-9 activation after coronary microembolization in rats. Exp Clin Cardiol. 2013;18(2):161-5.
25. Li L, Su Q, Wang Y, Dai R, Lu Y, Su B, et al. Effect of atorvastatin (Lipitor) on myocardial apoptosis and caspase-8 activation following coronary microembolization. Cell Biochem Biophys. 2011;61(2):399-406.
26. Zhang P, Shen M, Fernandez-Patron C, Kassiri Z. ADAMs family and relatives in cardiovascular physiology and pathology. J Mol Cell Cardiol. 2016;93:186-99.
27. Narasimhan M, Rajasekaran NS. Exercise, Nrf2 and antioxidant signaling in cardiac aging. Front Physiol. 2016;7:241.
28. Takemura G, Kanoh M, Minatoguchi S, Fujiwara H. Cardiomyocyte apoptosis in the failing heart--a critical review from definition and classification of cell death. Int J Cardiol. 2013;167(6):2373-86.
29. Keller KM, Howlett SE. Sex differences in the biology and pathology of the aging heart. Can J Cardiol. 2016;32(9):1065-73.
30. Dunlay SM, Roger VL. Gender differences in the pathophysiology, clinical presentation, and outcomes of ischemic heart failure. Curr Heart Fail Rep. 2012;9(4):267-76.